People · Operator
Named in public records as an officer, director or promoter · active 2020–2021 · Other Technology, Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Forian Inc. | — | Other Technology | Series B | $24.0M | $484.6M | 2021 |
| Medical Outcomes Research Analysis, LLC | — | Healthtech | Seed | $2.1M | $59.6M | 2020 |
Max Wygod at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Max Wygod on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Scott Ogur | 1 | 3 |
| Daniel Barton | 1 | 2 |
| Shahir Kassam-Adams | 1 | 2 |
| Kristiina Vuori | 1 | 2 |
| Alyssa Varadhan | 1 | 1 |
| Martin Wygod | 1 | 1 |
| Edward Spaniel | 1 | 1 |
| Jennifer Hajj | 1 | 1 |
| Adam Dublin | 1 | 1 |
| Ian Banwell | 1 | 1 |
| Michael Vesey | 1 | 1 |
| Mark Adler | 1 | 1 |
| Stanley Trotman | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.